Upcoming events
Sesh w/ our ACR Board Members
Happy belated 4/20.
We hope you had a spectacular “high” holiday and are ready to continue the sesh with our very own ACR Board members. Please join us for 2024’s first roundtable event in a “Ask Me Anything” type format. Learn more about the Asian Cannabis Roundtable and some of the initiatives we’ll be pursuing this year. We’d love input from interested stakeholders and to grow our community. Come join the movement!
Eventbrite link available HERE.
Ayr Wellness NJ Tour
Hop on the bus!
Join members of the Asian Cannabis Roundtable for lunch, as we tour the vertically integrated operations at Ayr Wellness' Woodbridge NJ facility. We will meet Tenisha Victor, Ayr's Director of Emerging Markets & Community Outreach and learn about opportunities to partner with Ayr.
Transportation will be provided to/from the upper west side of Manhattan.
Link to registration HERE.
Industry Brief: Rescheduling Cannabis to Schedule III on Controlled Substances Act
Join us for an exciting monthly online event, the Industry Brief! Get ready to dive into the latest trends and insights in the industry. Whether you're a seasoned professional or just starting out, this event is perfect for anyone looking to stay ahead of the game.
Starting on Thu Sep 14 2023 at 19:00:00 GMT-0400 (Eastern Daylight Time), our expert speakers will share their knowledge and experiences, giving you valuable tips and tricks to succeed in the industry.
Don't miss this opportunity to network with like-minded individuals, exchange ideas, and gain inspiration. Mark your calendars and join us for the Industry Brief online event!
This month will focus on the recent recommendation by President Biden's HHS Department to reclassify cannabis as a Schedule III drug. We will discuss how the DEA is likely to respond to HHS' recommendation, and what the likely timing of the DEA's finding will be. We will further explore what the legislative impacts of a Schedule III might be, and further what "symbolic" impact it might have on how banks, stock exchanges and other private actors engage with the cannabis industry. Finally, we will explore what the Schedule III finding means for legislation like the SAFE Banking Act and cannabis' state-led growth story across the country.
